Early metastases detection is the single most important factor to save lives. Our innovative automated detection process allows doctors to detect metastases earlier while being faster cost-effective way. RUBYnanome’s workflow delivers a full prognostic report for therapy monitoring and patient stratification in 2 hours. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
Health Care, Muscle-invasive, Circulating
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Ruby Nanomed? We’re happy to assist you with our Startup Sourcing service.